Search hospitals > Colorado > Boulder
Rocky Mountain Cancer Centers-Boulder
Claim this profileBoulder, Colorado 80304
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
217 reported clinical trials
9 medical researchers
Summary
Rocky Mountain Cancer Centers-Boulder is a medical facility located in Boulder, Colorado. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Cancer and other specialties. Rocky Mountain Cancer Centers-Boulder is involved with conducting 217 clinical trials across 369 conditions. There are 9 research doctors associated with this hospital, such as Nicholas DiBella, Robert M. Jotte, Sami Diab, and Keren Sturtz.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder6 years of reported clinical research
Expert in Skin Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Robert M. JotteGSK Investigational Site4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
11 drugs studied
Sami DiabRocky Mountain Cancer Centers8 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
5 reported clinical trials
11 drugs studied
Keren SturtzSCL Health Lutheran Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
4 reported clinical trials
14 drugs studied
Clinical Trials running at Rocky Mountain Cancer Centers-Boulder
Breast Cancer
Skin Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Cutaneous Melanoma
Breast cancer
Non-Small Cell Lung Cancer
Melanoma
Stomach Cancer
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rocky Mountain Cancer Centers-Boulder?
Rocky Mountain Cancer Centers-Boulder is a medical facility located in Boulder, Colorado. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Cancer and other specialties. Rocky Mountain Cancer Centers-Boulder is involved with conducting 217 clinical trials across 369 conditions. There are 9 research doctors associated with this hospital, such as Nicholas DiBella, Robert M. Jotte, Sami Diab, and Keren Sturtz.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.